Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
This case report documents that highly active antiretroviral therapy (HAART) can lead to the regression of Kaposi's sarcoma (KS) lesions in the auditory canal of an HIV-infected male from Chennai, India. In resource-limited settings where administering anti-KS chemotherapeutic agents may not be feasible, HAART alone can be an option in HIV-infected individuals with KS.
Kumarasamy
N
N
YRG Centre for AIDS Research and Education, Voluntary Health Services, Chennai, India. kumarasamy@yrgcare.org
Venkatesh
K K
KK
Devaleenol
B
B
Poongulali
S
S
Ahilasamy
N
N
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D004424:Ear Canal / Q000187:drug effects; D004428:Ear Neoplasms / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007194:India; D008297:Male; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome